Literature DB >> 32757378

In Vitro Assays to Study PD-1 Biology in Human T Cells.

Anna S Tocheva1, Shalom Lerrer2, Adam Mor2.   

Abstract

Our understanding of programmed cell death 1 (PD-1) biology is limited due to technical difficulties in establishing reproducible, yet simple, in vitro assays to study PD-1 signaling in primary human T cells. The protocols in this article were refined to test the consequences of PD-1 ligation on short-term T cell signaling, long-term T cell function, and the structural consequences of PD-1 ligation with PD-1 ligands. Basic Protocol 1 addresses the need for a robust and reproducible short-term assay to examine the signaling cascade triggered by PD-1. We describe a phospho flow cytometry method to determine how PD-1 ligation alters the level of CD3ζ phosphorylation on Tyr142 , which can be easily applied to other proximal signaling proteins. Basic Protocol 2 describes a plate-bound assay that is useful to examine the long-term consequences of PD-1 ligation such as cytokine production and T cell proliferation. Complementary to that, Basic Protocol 3 describes an in vitro superantigen-based assay to evaluate T cell responses to therapeutic agents targeting the PD-1/PD-L axis, as well as immune synapse formation in the presence of PD-1 engagement. Finally, in Basic Protocol 4 we outline a tetramer-based method useful to interrogate the quality of PD-1/PD-L interactions. These protocols can be easily adapted for mouse studies and other inhibitory receptors. They provide a valuable resource to investigate PD-1 signaling in T cells and the functional consequences of various PD-1-based therapeutics on T cell responses.
© 2020 Wiley Periodicals LLC. Basic Protocol 1: PD-1 crosslinking assay to determine CD3ζ phosphorylation in primary human T cells Basic Protocol 2: Plate-based ligand binding assay to study PD-1 function in human T cells Support Protocol 1: T cell proliferation assay in the presence of PD-1 ligation Basic Protocol 3: In vitro APC/T cell co-culture system to evaluate therapeutic interventions targeting the PD-1/PD-L1 axis Support Protocol 2: Microscopy-based approach to evaluate the consequences of PD-1 ligation on immune synapse formation Basic Protocol 4: Tetramer-based approach to study PD-1/PD-L1 interactions. © 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  PD-1; PD-1 ligation; PD-L1; PD-L2; T cell signaling; primary human T cells

Mesh:

Substances:

Year:  2020        PMID: 32757378      PMCID: PMC9199350          DOI: 10.1002/cpim.103

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  7 in total

1.  PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta.

Authors:  Kelly-Ann Sheppard; Lori J Fitz; Julie M Lee; Christina Benander; Judith A George; Joe Wooters; Yongchang Qiu; Jason M Jussif; Laura L Carter; Clive R Wood; Divya Chaudhary
Journal:  FEBS Lett       Date:  2004-09-10       Impact factor: 4.124

2.  PLCε1 regulates SDF-1α-induced lymphocyte adhesion and migration to sites of inflammation.

Authors:  Marianne Strazza; Inbar Azoulay-Alfaguter; Michael Peled; Alan V Smrcka; Edward Y Skolnik; Shekhar Srivastava; Adam Mor
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-17       Impact factor: 11.205

3.  T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.

Authors:  Enfu Hui; Jeanne Cheung; Jing Zhu; Xiaolei Su; Marcus J Taylor; Heidi A Wallweber; Dibyendu K Sasmal; Jun Huang; Jeong M Kim; Ira Mellman; Ronald D Vale
Journal:  Science       Date:  2017-03-09       Impact factor: 47.728

4.  Affinity purification mass spectrometry analysis of PD-1 uncovers SAP as a new checkpoint inhibitor.

Authors:  Michael Peled; Anna S Tocheva; Sabina Sandigursky; Shruti Nayak; Elliot A Philips; Kim E Nichols; Marianne Strazza; Inbar Azoulay-Alfaguter; Manor Askenazi; Benjamin G Neel; Adam J Pelzek; Beatrix Ueberheide; Adam Mor
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-27       Impact factor: 11.205

5.  MHC-Peptide Tetramers to Visualize Antigen-Specific T Cells.

Authors:  John D Altman; Mark M Davis
Journal:  Curr Protoc Immunol       Date:  2016-11-01

6.  PD-L1 regulates the development, maintenance, and function of induced regulatory T cells.

Authors:  Loise M Francisco; Victor H Salinas; Keturah E Brown; Vijay K Vanguri; Gordon J Freeman; Vijay K Kuchroo; Arlene H Sharpe
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

7.  Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells.

Authors:  Yunlong Zhao; Devin L Harrison; Yuran Song; Jie Ji; Jun Huang; Enfu Hui
Journal:  Cell Rep       Date:  2018-07-10       Impact factor: 9.423

  7 in total
  1 in total

1.  Small-molecule PD-L1 inhibitor BMS1166 abrogates the function of PD-L1 by blocking its ER export.

Authors:  Fang-Fang Chen; Zheng Li; Dawei Ma; Qiang Yu
Journal:  Oncoimmunology       Date:  2020-10-14       Impact factor: 8.110

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.